Sold as Inulin And Sodium Chloride. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 1 application for Inulin (sold as Inulin And Sodium Chloride), first approved Apr 30, 1940, with 0 new uses approved and 0 published complete response letters.
| Study | Phase | Status | Posted |
|---|---|---|---|
| A Clinical Trial to Evaluate the Effects of a Supplement on Gut HealthGut Health, Bloating · Peach Perfect | Not applicable | Recruiting | Nov 10, 2026 |
| Effect of Synbiotic Therapy on Renal Function Outcomes in Patients With Chronic Kidney Disease Stage III-IV: A Double-blind Randomized Placebo-controlled Trial.Chronic Kidney Disease (Stage 3-4) · Chittagong Medical College | Not applicable | Recruiting | Nov 3, 2026 |
| Stanford University Neurofiber StudyPARKINSON DISEASE (Disorder) · Stanford University | Phase 1 | Not yet recruiting | Nov 3, 2026 |
| Effects of a 12-Week Solid Beverage Intervention on Suboptimal Health StatusMetabolic Disorder, Sub-health Status · ChinaNorm | Not applicable | Recruiting | Oct 20, 2026 |
| High-Resolution Measurements of Diet-Microbiome InteractionsIBS (Irritable Bowel Syndrome) · Stanford University | Not applicable | Not yet recruiting | Oct 5, 2026 |
| Whole Food Fibers for Support of Key Gut Bacteria for Human HealthPrediabetes or Overweight · Purdue University | Not applicable | Not yet recruiting | Sep 24, 2026 |
| Effect of Agave Consumption on Performance and Gut Microbiota in Adults Undergoing Physical TrainingDysbiosis · National Polytechnic Institute, Mexico | Not applicable | Enrolling by invitation | Sep 18, 2026 |
| Synbiotic LA-5 and Agave Inulin for Mild Cognitive ImpairmentCognitive Impairment · Anahuac University | Not applicable | Recruiting | Sep 14, 2026 |
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Apr 30, 1940 | Inulin And Sodium ChlorideNDA 2282 · New combination | Iso Tex | 11 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
